As of April 19, 2025, Achieve Life Sciences (ACHV) has a market cap of $69.023 million USD. According to our data, Achieve Life Sciences is ranked No.7848 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $69.02 M |
-42.98%
|
Dec 31, 2024 | $0.12 B |
-14.56%
|
Dec 29, 2023 | $0.14 B |
68.16%
|
Dec 30, 2022 | $84.26 M |
-68.51%
|
Dec 31, 2021 | $0.27 B |
-3.95%
|
Dec 31, 2020 | $0.28 B |
-23.58%
|
Dec 31, 2019 | $0.36 B |
-56.20%
|
Dec 31, 2018 | $0.83 B |
-90.97%
|
Dec 29, 2017 | $9.22 B |
-75.64%
|
Dec 30, 2016 | $37.83 B |
-58.68%
|
Dec 31, 2015 | $91.55 B |
-47.16%
|
Dec 31, 2014 | $173.26 B |
-72.54%
|
Dec 31, 2013 | $630.99 B |
-36.43%
|
Dec 31, 2012 | $992.63 B |
11.75%
|
Dec 30, 2011 | $888.22 B |
-30.08%
|
Dec 31, 2010 | $1.270 T |
-24.64%
|
Dec 31, 2009 | $1.686 T |
642.67%
|
Dec 31, 2008 | $226.97 B |
-62.12%
|
Dec 31, 2007 | $599.21 B |
-92.80%
|
Dec 29, 2006 | $8.321 T |
21.47%
|
Dec 30, 2005 | $6.850 T |
42.49%
|
Dec 31, 2004 | $4.807 T |
-30.51%
|
Dec 31, 2003 | $6.918 T |
139.62%
|
Dec 31, 2002 | $2.887 T |
-73.76%
|
Dec 31, 2001 | $11.004 T |
1,192.80%
|
Dec 29, 2000 | $851.15 B |
-75.00%
|
Dec 31, 1999 | $3.405 T |
-62.96%
|
Dec 31, 1998 | $9.192 T |
-79.62%
|
Dec 31, 1997 | $45.111 T |
11.34%
|
Dec 31, 1996 | $40.515 T |
142.86%
|
Dec 29, 1995 | $16.683 T |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
Market Cap | = | ACHV Stock Price | * | ACHV Shares Outstanding |
= | $1.99 | * | 34.69 M | |
= | $69.02 M |